Prot #ANG1005-CLN-04: A Phase II, Open-Label, Multi-Center Study of ANG1005 in HER2+ Breast Cancer Patients with Progressive/Recurrent Brain Metastases

Project: Research project

Project Details

StatusFinished
Effective start/end date2/10/142/10/19

Funding

  • AngioChem Inc. (Prot #ANG1005-CLN-04)